content_image/158479.jpg content_image/158481.jpg
## PERFORMANCE GRAPH 

The following performance graph compares the performance of Bristol-Myers Squibb for the periods indicated with the performance of the Standard & Poor’s 500 Stock Index (S&P 500) and the average performance of a group consisting of our peer corporations on a line-of-business basis. The corporations making up our Peer Group are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Biogen Idec Inc., Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Roche Holding Ltd., and Sanofi. 

Total return indices reflect reinvested dividends and are weighted using beginning-period market capitalization for each of the reported time periods. 

<img src='content_image/158479.jpg'>

<img src='content_image/158481.jpg'>

Assumes $100 invested on 12/31/07 in Bristol-Myers Squibb common stock, S&P 500 Index, and Peer Group. Values are as of December 31 of specified year assuming dividends are reinvested. 

